40 participants
A Study to Evaluate the Safety and Pharmacokinetics of Eflapegrastim in Pediatric Participants With Solid Tumors or Lymphomas and Treated With Myelosuppressive Chemotherapy
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-09-01
- Start Date:
- 2021-05-20
- Completion:
- 2027-10-31
Conditions
- Solid Tumors
- Lymphoma
Interventions
- DRUG
No Results Yet